Edgestream Partners L.P. Trims Holdings in Humana Inc. (NYSE:HUM)

Edgestream Partners L.P. lowered its holdings in shares of Humana Inc. (NYSE:HUM) by 69.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,314 shares of the insurance provider’s stock after selling 12,192 shares during the period. Edgestream Partners L.P.’s holdings in Humana were worth $1,986,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. CarsonAllaria Wealth Management Ltd. increased its holdings in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Hantz Financial Services Inc. acquired a new position in Humana in the 2nd quarter valued at $35,000. Family Firm Inc. purchased a new position in Humana during the 2nd quarter worth $37,000. Riverview Trust Co acquired a new stake in shares of Humana in the 2nd quarter worth $44,000. Finally, Carolinas Wealth Consulting LLC boosted its holdings in shares of Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after acquiring an additional 74 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HUM. Piper Sandler assumed coverage on Humana in a report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price objective on the stock. TD Cowen boosted their price objective on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. JPMorgan Chase & Co. increased their target price on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Robert W. Baird initiated coverage on Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target on the stock. Finally, Morgan Stanley assumed coverage on Humana in a report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. Thirteen research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $398.70.

Humana Stock Down 1.0 %

Shares of NYSE HUM opened at $312.00 on Friday. The firm has a market cap of $37.60 billion, a P/E ratio of 19.43, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The firm’s 50 day moving average price is $359.14 and its 200 day moving average price is $345.90.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $8.94 earnings per share. As a group, sell-side analysts anticipate that Humana Inc. will post 16 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.